Triple

T16185448
Position Surface form Disambiguated ID Type / Status
Subject Office of Translational Sciences E392787 entity
Predicate website P69 FINISHED
Object https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/office-translational-sciences E392787 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/office-translational-sciences | Statement: [Office of Translational Sciences, website, https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/office-translational-sciences]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/office-translational-sciences
Context triple: [Office of Translational Sciences, website, https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/office-translational-sciences]
  • A. Office of Translational Sciences chosen
    The Office of Translational Sciences is a scientific office within the U.S. Food and Drug Administration that advances the translation of biomedical research into safe and effective drug therapies through regulatory science, research, and policy development.
  • B. U.S. Food and Drug Administration Office of Regulatory Science
    The U.S. Food and Drug Administration Office of Regulatory Science is an FDA division that conducts scientific research and analysis to support regulatory decisions on the safety, effectiveness, and quality of food, drugs, and other products under the agency’s oversight.
  • C. Center for Drug Evaluation and Research
    The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
  • D. Center for Biologics Evaluation and Research
    The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
  • E. U.S. Food and Drug Administration Office of Operations
    The U.S. Food and Drug Administration Office of Operations is the FDA component responsible for overseeing the agency’s administrative, financial, and operational support functions across its programs and facilities.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d87f1e49ac8190a311b54d32990576 completed April 10, 2026, 4:39 a.m.
NER Named-entity recognition batch_69e22060dcf88190b7c662946a5f0191 completed April 17, 2026, 11:58 a.m.
NED1 Entity disambiguation (via context triple) batch_69ffff0550b48190ac84946b7254552b completed May 10, 2026, 3:44 a.m.
Created at: April 10, 2026, 5:02 a.m.